Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
1
|
| pubmed:dateCreated |
1991-4-17
|
| pubmed:abstractText |
A total of 55 patients with epithelial ovarian carcinoma treated with platinum-based chemotherapy were followed for a minimum period of 2 years. Of these 22 patients had a prechemotherapy serum CA125 level of less than 50 ku/l and 33 patients had a serum CA125 level of greater than or equal to 50 ku/l. The 5-year actuarial survival of the two groups were 75% and 10% respectively. Prechemotherapy CA125 level taken 4 weeks after debulking surgery may predict the eventual survival outcome in epithelial ovarian cancer patients who undergo chemotherapy treatment.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Jan
|
| pubmed:issn |
0936-6555
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
3
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
32-6
|
| pubmed:dateRevised |
2008-3-10
|
| pubmed:meshHeading |
pubmed-meshheading:2001340-Antigens, Tumor-Associated, Carbohydrate,
pubmed-meshheading:2001340-Carcinoma,
pubmed-meshheading:2001340-Female,
pubmed-meshheading:2001340-Humans,
pubmed-meshheading:2001340-Ovarian Neoplasms,
pubmed-meshheading:2001340-Prognosis,
pubmed-meshheading:2001340-Survival Rate,
pubmed-meshheading:2001340-Tumor Markers, Biological
|
| pubmed:year |
1991
|
| pubmed:articleTitle |
Prechemotherapy serum CA125 level as a predictor of survival outcome in epithelial carcinoma of the ovary.
|
| pubmed:affiliation |
Department of Radiotherapy, Leicester Royal Infirmary, UK.
|
| pubmed:publicationType |
Journal Article
|